SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001759425-24-000011
Filing Date
2024-04-23
Accepted
2024-04-23 16:20:09
Documents
8
Period of Report
2024-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A mirm-schedule14proxyx20240.htm DEF 14A 689442
2 chart-2d7123a0266e42c6835.jpg GRAPHIC 76084
3 chart-866a43d584384171bfe.jpg GRAPHIC 82139
4 image_1a.jpg GRAPHIC 16339
5 image_2a.jpg GRAPHIC 9723
6 image_41a.jpg GRAPHIC 10774
7 page1.jpg GRAPHIC 149905
8 page2.jpg GRAPHIC 151897
  Complete submission text file 0001759425-24-000011.txt   1363831
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38981 | Film No.: 24865085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)